The 2011 published research paper, “Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent” was recently reviewed and confirmed that CBD is completely safe.
“An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies” published in Cannabis and Cannabinoid Research found, “In general, the often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research. The majority of studies were performed for treatment of epilepsy and psychotic disorders. Here, the most commonly reported side effects were tiredness, diarrhea, and changes of appetite/weight. In comparison with other drugs, used for the treatment of these medical conditions, CBD has a better side effect profile. This could improve patients’ compliance and adherence to treatment.”
In the update Iffland Kerstin and Grotenhermen Franjo went on to find, “At lower doses, it [CBD] has physiological effects that promote and maintain health, including antioxidative, anti-inflammatory, and neuroprotection effects. For instance, CBD is more effective than vitamin C and E as a neuroprotective antioxidant and can ameliorate skin conditions such as acne.”
You can read the entire text of “An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies” here.
Want a better source declaring the safety of CBD Oil? How about WHO (World Health Organization)? In December 2017 WHO’s Expert Committee on Drug Dependence came out with a statement declaring that cannabidiol is no t an addictive chemical and poses no threat to public health. WHO suggests that there’s no scientific basis for prohibiting the cannabidiol. Not only is CBD not addictive, but the report goes onto to show promising potential for addicts, “Another possible therapeutic application which has been investigated is the use of CBD to treat drug addiction. A recent systematic review concluded that there were a limited number of preclinical studies which suggest that CBD may have therapeutic properties on opioid, cocaine, and psychostimulant addiction, and some preliminary data suggest that it may be beneficial in cannabis and tobacco addiction in humans,” from CANNABIDIOL (CBD) Pre-Review Report
Agenda, Item 5.2 Expert Committee on , Drug Dependence 6-10 November 2017.
